Biomarkers in Hematologic Malignancies: A Focus on CLL and Multiple Myeloma
-
Register
- Non-member - Free!
- Member - Free!
This webinar is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account in order to register.
If You DO NOT Have an ACCC Account:
- To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.
- ACCC and State Society Members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page.
- Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page.
- Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
- The green box in the upper right corner of this page will indicate “You are registered!” for this course!
If You Have an ACCC Account:
- Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.
- You will be automatically redirected back to webinar page, and the green box in the upper right corner will say that “You are registered!” for this course!
PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!
For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer users may experience difficulties accessing the webinar.
Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this webinar. For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.
Two thought leaders who have deep knowledge of--and experience in--biomarker testing in patients with hematologic malignancies will discuss best practices for biomarker testing in chronic lymphocytic leukemia (CLL) and multiple myeloma based on patient case discussions and the latest guidelines.
Speakers:
Lindsey Roeker, MD
Hematologic Oncologist, Memorial Sloan Kettering Cancer Center
Urvi Shah, MD
Hematologic Oncologist, Memorial Sloan Kettering Cancer Center
This webinar is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account in order to register. Please click the "Registration Instructions" tab for more details.
This webinar is part of the ACCC education program, BiomarkerLIVE. This project is supported by AbbVie, AstraZeneca, Lilly Oncology, and Merck & Co., Inc.
Lindsey Roeker, MD
Hematologic Oncologist
Memorial Sloane Kettering Cancer
Lindsey Roeker is a clinical researcher and member of the chronic lymphocytic leukemia (CLL) program within the leukemia service at Memorial Sloan Kettering Cancer Center in New York, NY. She hails from Wisconsin, attended medical school at Mayo Clinic School of Medicine, and completed Internal Medicine Residency at Brigham and Women’s Hospital. She was a fellow and chief fellow at Memorial Sloan Kettering Cancer Center and completed her training in July 2020. She was recognized for her contributions to teaching and research with awards including the John Mendelsohn Housestaff Teaching Award and American Society of Hematology Research Training Award for Fellows. She has since joined faculty at MSKCC where her clinical research interests are in novel treatment approaches and minimization of toxicity for patients with CLL. She is further involved in a consortium of investigators who aim to use real world data to address unanswered questions in the care of patients with CLL and collaborates with translational scientists to uncover drug resistance mechanisms and immune repertoire perturbations that predict toxicity and response to CLL-directed therapy.
Lindsey Roeker is a clinical researcher and member of the chronic lymphocytic leukemia (CLL) program within the leukemia service in at Memorial Sloan Kettering Cancer Center. her clinical research interests are in novel treatment approaches and minimization of toxicity for patients with CLL
Urvi A. Shah, MD
Hematologic Oncologist
Memorial Sloan Kettering Cancer Center
Dr. Shah is a Clinical Investigator and an Assistant Attending on the Myeloma Service at Memorial Sloan Kettering Cancer Center and a member of the Junior Faculty Council. She completed fellowships in hematology/oncology at Montefiore Medical Center, and in cancer immunotherapy by MSK and the Parker Institute for Cancer Immunotherapy in New York. She is board certified in Internal Medicine, Hematology and Medical Oncology.
Her clinical and translational research focuses on nutritional and metabolic factors in plasma cell disorders as well as immune therapies. She is studying the link between nutrition and myeloma via immune, epigenetic and microbiome mechanisms. Her research includes clinical retrospective projects, clinical prospective trials, and translational collaborative research. She opened the first nutrition trial in plasma cell disorders to date in 2021 (NUTRIVENTION study) that is currently enrolling. She is the principal investigator (PI) of four investigator-initiated trials and a co-PI / site PI of several others.
She is supported by the NCI Paul Calabresi K12, Parker Institute for Cancer Immunotherapy and International Myeloma Society Career Development Awards. Her research is also funded by the Health Tree Foundation, Paula and Rodger Riney Foundation and Allen Foundation. She has received the ASH CRTI Award, ECOG ACRIN Young Investigator Translational Research Award, Henry Moses Prize and Celgene Future Leaders in Hematology Award.
Key:
Complete
Next
Failed
Available
Locked
